Curran departs as chair of NRG Oncology“It would be nice at least once in my life to have just one job” January 22, 2021Vol.47 No.03By Paul Goldberg
Sharpless employment status is unknown, but in previous transitions NCI directors have stayed on January 22, 2021Vol.47 No.03By Paul Goldberg
Free Cancer groups expect bold moves reminiscent of the 2016 Moonshot as Biden tackles COVID-19, inequity, injustice January 22, 2021Vol.47 No.03By Matthew Bin Han Ong
Trials & Tribulations An oncologist’s perspective on measuring success in the clinic January 15, 2021Vol.47 No.02By Steven R. Grossman
FDA to update labels for generic cancer drugs with signing of MODERN Labeling Act January 15, 2021Vol.47 No.02By Matthew Bin Han Ong
Improvements in treatments for NSCLC, blood cancers, and melanoma continue to accelerate annual drop in overall cancer mortality rates January 15, 2021Vol.47 No.02By Alexandria Carolan and Matthew Bin Han Ong
Conversation with The Cancer Letter Sean Khozin named CEO of CancerLinQ: AI is here, and it will become even more democratized January 15, 2021Vol.47 No.02By Matthew Bin Han Ong
Cancer History ProjectFree Gordon Zubrod’s panoramic vision shaped modern clinical cancer researchThe Cancer History Project finds and publishes Zubrod's autobiography January 15, 2021Vol.47 No.02By Otis W. Brawley and Paul Goldberg
COVID-19 & CancerFree Cancer groups urge CDC to prioritize cancer patients for COVID-19 vaccination January 08, 2021Vol.47 No.01By Matthew Bin Han Ong
